MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Parkinson disease subtype stability and eventual convergence

    H. Lessov-Schlaggar, A. Eid, T. Cash, E. Foster, B. Maiti, H. Hwang, R. Perrin, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To determine the longitudinal stability of Parkinson disease (PD) subtype membership. Background: Previous research demonstrates distinct PD subtypes of “motor only”, “psychiatric & motor”,…
  • 2025 International Congress

    Exploratory Longitudinal Analysis of Lifestyle and Parkinson’s Disease Symptoms

    N. Meier, O. Di Martino, I. Chaturvedi (Irvine, USA)

    Objective: This study is an exploratory longitudinal analysis of lifestyle factors and Parkinson’s Disease (PD) symptoms that may inform targeted research into specific lifestyle interventions…
  • 2025 International Congress

    The relationship between synuclein-related biomarkers and people with upper-respiratory causes of hyposmia or persistent hyposmia

    E. Brown, T. Tropea, A. Siderowf, L. Heathers, T. Foroud, C. Gochanour, C. Caspell-Garcia, M. Marshall, R. Kurth, T. Simuni, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To determine how smell-testing can enrich screening for individuals with biomarkers related to neuronal alpha-synucleinopathy-related neurodegeneration (NSD). Background: Loss of sense of smell is the…
  • 2025 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

    A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: This study aimed to evaluate the prevalence of CI in a diverse group of patients with PD in Dhaka, Bangladesh. This study also aimed…
  • 2025 International Congress

    Parkinson’s disease overlapping with other neurodegeneration-case series with neuropathological description.

    L. Milanowski, A. Salinska, A. Acewicz, M. Grzegorczyk, S. Tarka, S. Szlufik, T. Wierzba-Bobrowicz, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of the study is to report Parkinson’s disease (PD) case series with co-occurening amyotrophic lateral sclerosis (ALS) and neuropathologically characterize one case.…
  • 2025 International Congress

    Automatic quantification of motor symptoms including freezing of gait in Parkinson’s disease through motion capture

    W. Sako, M. Osawa, T. Iguchi, T. Hara, H. Haginiwa, S. Haji, N. Hattori (Bunkyo, Japan)

    Objective: The aim of this study was to quantify the motor symptoms of Parkinson's disease (PD), including freezing of gait, using a motion capture device.…
  • 2025 International Congress

    Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy

    V. Arca, J. Jurkeviciene, S. Wrigley, P. Cullinane, J. Parmera, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: to describe the rate of levodopa response, phenotypical characteristics, prognostic implications and pathological features in a large cohort of patients with pathology-confirmed Parkinson’s disease…
  • 2025 International Congress

    Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers

    H. Khelifa, A. R. Al-Ihribat, H. Smeda, A. Hendawy, A. Abunamoos (Oran, Algeria)

    Objective: To update the available data on the prevalence of cancer among patients with Parkinson’s Disease (PD) and the prevalence of PD among cancer patients…
  • 2025 International Congress

    Frequency of Falls in the Parkinson’s Progression Markers Initiative

    J. Vizcarra, D. Lafontant, A. Siderowf (Philadelphia, USA)

    Objective: To determine the faller rate across years since diagnosis and neuronal α-synuclein disease integrated staging system (NSD-ISS) stages in the Parkinson's Progression Markers Initiative…
  • 2025 International Congress

    Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records

    J. Heller, K. Fitzgerald (Baltimore, USA)

    Objective: To explore the ability for electronic health records to identify persons with prodromal Parkinson’s disease in a cohort of those with RBD in the…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley